Innoviva Inc. (INVA) NASDAQ
$14.95 0.26 (1.77%)
Market Cap: $945.25M
As of 04/19/24 04:00 PM EDT. Market closed.
Innoviva Inc. (INVA)
NASDAQ
$14.95
0.26 (1.77%)
Market Cap: $945.25M
As of 04/19/24 04:00 PM EDT. Market closed.
innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. innoviva's portfolio is anchored by the respiratory assets partnered with glaxo group limited (gsk), including relvar®/breo® ellipta® and anoro® ellipta®, which were jointly ... read more
innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. innoviva's portfolio is anchored by the respiratory assets partnered with glaxo group limited (gsk), including relvar®/breo® ellipta® and anoro® ellipta®, which were jointly developed by innoviva and gsk. under the agreement with gsk, innoviva is eligible to receive associated royalty revenues from relvar®/breo® ellipta®, anoro® ellipta® and, if approved and commercialized, vi monotherapy, as well. in addition, innoviva retains a 15 percent economic interest in future payments made by gsk for earlier-stage programs partnered with theravance biopharma, inc. for more information, please visit innoviva's website at www.inva.com. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Basso Stephen | Chief Financial Officer | Mar 05, 2024 | Option Exercise | $14.88 | 12,096 | 179,988 | 12,096 | Mar 07, 2024, 07:04 PM |
Ronsheim Matthew | See Remarks | Mar 05, 2024 | Option Exercise | $14.88 | 12,768 | 189,988 | 40,778 | Mar 07, 2024, 07:02 PM |
Zhen Marianne | Chief Accounting Officer | Mar 05, 2024 | Option Exercise | $14.88 | 10,752 | 159,990 | 47,566 | Mar 07, 2024, 07:00 PM |
Ronsheim Matthew | See Remarks | Feb 20, 2024 | Option Exercise | $15.80 | 807 | 12,751 | 28,010 | Feb 22, 2024, 09:31 PM |
Zhen Marianne | Chief Accounting Officer | Feb 20, 2024 | Option Exercise | $15.80 | 2,862 | 45,220 | 36,814 | Feb 22, 2024, 09:30 PM |
Ronsheim Matthew | See Remarks | Jan 18, 2024 | Option Exercise | $16.05 | 1,600 | 25,680 | 28,817 | Jan 22, 2024, 09:16 PM |
Zhen Marianne | Chief Accounting Officer | Nov 15, 2023 | Sale | $13.99 | 10,994 | 153,810 | 45,563 | Nov 17, 2023, 04:30 PM |
Zhen Marianne | Chief Accounting Officer | Aug 18, 2023 | Option Exercise | $13.64 | 785 | 10,707 | 51,152 | Aug 31, 2023, 01:58 PM |
DENNER ALEXANDER J | 10% Owner | Jun 06, 2023 | Buy | $13.05 | 8,000 | 104,384 | 7,215,000 | Jun 07, 2023, 08:10 PM |
DENNER ALEXANDER J | 10% Owner | Jun 05, 2023 | Buy | $13.04 | 7,000 | 91,297 | 7,207,000 | Jun 07, 2023, 08:10 PM |
DENNER ALEXANDER J | 10% Owner | May 26, 2023 | Buy | $13.12 | 30,000 | 393,729 | 7,080,000 | May 30, 2023, 07:01 PM |
DENNER ALEXANDER J | 10% Owner | May 25, 2023 | Buy | $13.09 | 50,000 | 654,330 | 7,050,000 | May 30, 2023, 07:01 PM |
DENNER ALEXANDER J | 10% Owner | May 30, 2023 | Buy | $13.01 | 120,000 | 1,560,648 | 7,200,000 | May 30, 2023, 07:01 PM |
Zhen Marianne | Chief Accounting Officer | May 19, 2023 | Option Exercise | $13.47 | 784 | 10,560 | 51,937 | May 23, 2023, 04:30 PM |
DENNER ALEXANDER J | 10% Owner | May 19, 2023 | Buy | $13.48 | 36,000 | 485,147 | 7,000,000 | May 19, 2023, 09:12 PM |
DENNER ALEXANDER J | 10% Owner | May 18, 2023 | Buy | $13.05 | 10,000 | 130,538 | 6,964,000 | May 19, 2023, 09:12 PM |
DENNER ALEXANDER J | 10% Owner | May 17, 2023 | Buy | $13.07 | 50,000 | 653,690 | 6,954,000 | May 19, 2023, 09:12 PM |
DENNER ALEXANDER J | 10% Owner | May 17, 2023 | Buy | $13.07 | 50,000 | 653,690 | 6,954,000 | May 19, 2023, 08:00 PM |
DENNER ALEXANDER J | 10% Owner | May 18, 2023 | Buy | $13.05 | 10,000 | 130,538 | 6,964,000 | May 19, 2023, 08:00 PM |
DENNER ALEXANDER J | 10% Owner | May 11, 2023 | Buy | $12.34 | 290,000 | 3,577,411 | 6,904,000 | May 15, 2023, 09:09 PM |
Raifeld Pavel | Chief Executive Officer | Mar 10, 2023 | Buy | $10.87 | 3,000 | 32,603 | 9,799 | Mar 14, 2023, 05:00 PM |
Zhen Marianne | Chief Accounting Officer | Feb 17, 2023 | Option Exercise | $12.42 | 1,852 | 23,002 | 36,801 | Feb 22, 2023, 04:31 PM |
Zhen Marianne | Chief Accounting Officer | Nov 18, 2022 | Option Exercise | $13.55 | 828 | 11,219 | 38,653 | Nov 22, 2022, 04:30 PM |
Zhen Marianne | Chief Accounting Officer | Aug 19, 2022 | Option Exercise | $14.12 | 830 | 11,720 | 39,048 | Aug 22, 2022, 06:16 PM |
Zhen Marianne | Chief Accounting Officer | May 20, 2022 | Option Exercise | $16.29 | 828 | 13,488 | 39,878 | May 23, 2022, 04:31 PM |
Zhen Marianne | Chief Accounting Officer | Feb 18, 2022 | Option Exercise | $19.99 | 2,277 | 45,517 | 32,181 | Feb 22, 2022, 05:06 PM |
Zhen Marianne | Chief Accounting Officer | Nov 19, 2021 | Option Exercise | $17.05 | 758 | 12,924 | 34,458 | Nov 22, 2021, 05:01 PM |
Zhen Marianne | Chief Accounting Officer | Aug 20, 2021 | Sale | $15.89 | 1,129 | 17,940 | 35,364 | Aug 24, 2021, 11:50 AM |
Zhen Marianne | Chief Accounting Officer | Aug 20, 2021 | Option Exercise | $15.94 | 760 | 12,114 | 34,604 | Aug 23, 2021, 05:02 PM |
Zhen Marianne | Chief Accounting Officer | Aug 19, 2021 | Sale | $16.02 | 2,802 | 44,888 | 36,493 | Aug 23, 2021, 05:02 PM |
Zhen Marianne | Chief Accounting Officer | Aug 20, 2021 | Sale | $15.89 | 1,129 | 17,940 | 35,364 | Aug 23, 2021, 05:02 PM |
Bickerstaff George | Director | May 24, 2021 | Buy | $13.46 | 10,000 | 134,619 | 124,560 | May 25, 2021, 06:44 PM |
Bickerstaff George | Director | May 21, 2021 | Buy | $12.97 | 10,000 | 129,670 | 114,560 | May 25, 2021, 06:44 PM |
Zhen Marianne | Chief Accounting Officer | Feb 19, 2021 | Option Exercise | $11.74 | 2,108 | 24,748 | 28,094 | Feb 22, 2021, 07:21 PM |
Zhen Marianne | Chief Accounting Officer | Nov 20, 2020 | Option Exercise | $10.95 | 798 | 8,738 | 30,202 | Nov 23, 2020, 05:04 PM |
Zhen Marianne | Chief Accounting Officer | Aug 20, 2020 | Option Exercise | $13.19 | 797 | 10,512 | 30,243 | Aug 24, 2020, 04:15 PM |
HULME GEOFFREY | Interim Principal Exec Officer | May 20, 2020 | Option Exercise | $14.10 | 339 | 4,780 | 46,251 | May 22, 2020, 04:15 PM |
Zhen Marianne | Chief Accounting Officer | May 20, 2020 | Option Exercise | $14.10 | 866 | 12,211 | 31,040 | May 22, 2020, 04:15 PM |
HULME GEOFFREY | Interim Principal Exec Officer | Feb 20, 2020 | Option Exercise | $15.10 | 1,549 | 23,390 | 29,735 | Feb 24, 2020, 04:42 PM |
Zhen Marianne | Chief Accounting Officer | Feb 20, 2020 | Option Exercise | $15.10 | 2,073 | 31,302 | 24,867 | Feb 24, 2020, 04:40 PM |
Zhen Marianne | Chief Accounting Officer | Feb 24, 2020 | Sale | $14.78 | 2,954 | 43,660 | 21,913 | Feb 24, 2020, 04:40 PM |
Zhen Marianne | Chief Accounting Officer | Nov 20, 2019 | Option Exercise | $12.59 | 602 | 7,579 | 26,940 | Nov 21, 2019, 08:45 PM |
HULME GEOFFREY | Interim PEO | Sep 04, 2019 | Option Exercise | $10.89 | 3,000 | 32,684 | 31,000 | Sep 06, 2019, 05:00 PM |
Zhen Marianne | Chief Accounting Officer | Aug 20, 2019 | Option Exercise | $11.50 | 600 | 6,900 | 27,542 | Aug 21, 2019, 07:23 PM |
Zhen Marianne | Chief Accounting Officer | May 20, 2019 | Option Exercise | $14.21 | 601 | 8,540 | 28,142 | May 23, 2019, 09:56 PM |
Bickerstaff George | Director | Feb 27, 2019 | Buy | $15.90 | 15,000 | 238,500 | 53,762 | Feb 28, 2019, 04:19 PM |
Zhen Marianne | Chief Accounting Officer | Feb 26, 2019 | Sale | $16.00 | 5,617 | 89,872 | 18,664 | Feb 28, 2019, 04:19 PM |
Zhen Marianne | Chief Accounting Officer | Feb 20, 2019 | Option Exercise | $14.67 | 1,353 | 19,849 | 24,281 | Feb 22, 2019, 05:28 PM |
Bickerstaff George | Director | Feb 21, 2019 | Buy | $14.90 | 10,000 | 148,958 | 38,762 | Feb 22, 2019, 05:27 PM |
HULME GEOFFREY | Interim PEO | Feb 19, 2019 | Option Exercise | $14.53 | 3,093 | 44,941 | 12,907 | Feb 22, 2019, 05:27 PM |
HULME GEOFFREY | Interim PEO | Feb 15, 2019 | Buy | $14.80 | 7,000 | 103,600 | 7,000 | Feb 20, 2019, 04:02 PM |
Zhen Marianne | Chief Accounting Officer | Nov 20, 2018 | Option Exercise | $16.43 | 540 | 8,872 | 25,634 | Nov 21, 2018, 04:35 PM |
Zhen Marianne | Chief Accounting Officer | Aug 20, 2018 | Option Exercise | $14.08 | 536 | 7,547 | 23,568 | Aug 22, 2018, 06:50 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Aug 20, 2018 | Option Exercise | $14.08 | 5,680 | 79,974 | 293,479 | Aug 22, 2018, 06:46 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Aug 21, 2018 | Sale | $14.10 | 8,000 | 112,840 | 285,479 | Aug 22, 2018, 06:46 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Aug 20, 2018 | Option Exercise | $14.08 | 3,089 | 43,493 | 256,271 | Aug 22, 2018, 06:43 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Aug 21, 2018 | Sale | $14.12 | 8,504 | 120,080 | 247,767 | Aug 22, 2018, 06:43 PM |
dEsparbes Eric | SVP and CFO | May 20, 2018 | Option Exercise | $14.59 | 7,901 | 115,276 | 376,965 | May 22, 2018, 07:53 PM |
dEsparbes Eric | SVP and CFO | May 21, 2018 | Sale | $14.40 | 5,808 | 83,623 | 373,081 | May 22, 2018, 07:53 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | May 20, 2018 | Option Exercise | $14.59 | 4,682 | 68,310 | 305,235 | May 22, 2018, 07:52 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | May 21, 2018 | Sale | $14.40 | 8,000 | 115,202 | 299,159 | May 22, 2018, 07:52 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | May 20, 2018 | Option Exercise | $14.59 | 3,089 | 45,069 | 259,360 | May 22, 2018, 07:47 PM |
dEsparbes Eric | Interim PEO, SVP and CFO | Feb 20, 2018 | Option Exercise | $16.44 | 24,876 | 408,961 | 297,188 | Feb 22, 2018, 04:24 PM |
dEsparbes Eric | Interim PEO, SVP and CFO | Feb 21, 2018 | Sale | $16.52 | 5,378 | 88,825 | 291,810 | Feb 22, 2018, 04:24 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Feb 20, 2018 | Option Exercise | $16.44 | 15,500 | 254,820 | 243,473 | Feb 22, 2018, 04:23 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Feb 20, 2018 | Option Exercise | $16.44 | 16,700 | 274,548 | 197,463 | Feb 22, 2018, 04:23 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Feb 21, 2018 | Sale | $16.51 | 8,000 | 132,100 | 235,473 | Feb 22, 2018, 04:23 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Feb 21, 2018 | Sale | $16.60 | 9,890 | 164,148 | 187,573 | Feb 22, 2018, 04:23 PM |
Aguiar Michael W | President & Chief Exec Officer | Dec 04, 2017 | Sale | $13.13 | 12,022 | 157,791 | 980,907 | Dec 05, 2017, 05:17 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Nov 20, 2017 | Option Exercise | $13.17 | 14,757 | 194,350 | 226,800 | Nov 22, 2017, 04:53 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Nov 21, 2017 | Sale | $13.29 | 13,000 | 172,795 | 213,800 | Nov 22, 2017, 04:53 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Nov 20, 2017 | Option Exercise | $13.17 | 3,358 | 44,225 | 263,866 | Nov 22, 2017, 04:52 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Nov 21, 2017 | Sale | $13.26 | 5,215 | 69,145 | 258,651 | Nov 22, 2017, 04:52 PM |
dEsparbes Eric | SVP and CFO | Nov 20, 2017 | Option Exercise | $13.17 | 6,141 | 80,877 | 337,027 | Nov 22, 2017, 04:51 PM |
dEsparbes Eric | SVP and CFO | Nov 21, 2017 | Sale | $13.31 | 13,460 | 179,171 | 321,742 | Nov 22, 2017, 04:51 PM |
dEsparbes Eric | SVP and CFO | Nov 20, 2017 | Sale | $13.04 | 1,825 | 23,798 | 335,202 | Nov 22, 2017, 04:51 PM |
Aguiar Michael W | President & Chief Exec Officer | Nov 20, 2017 | Option Exercise | $13.17 | 43,038 | 566,810 | 992,929 | Nov 22, 2017, 04:43 PM |
Faerm Michael E. | Sr VP & Chief Business Officer | Nov 20, 2017 | Option Exercise | $13.17 | 4,470 | 58,870 | 279,422 | Nov 22, 2017, 04:42 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Aug 20, 2017 | Option Exercise | $12.28 | 2,886 | 35,440 | 267,224 | Aug 22, 2017, 04:38 PM |
Aguiar Michael W | President & Chief Exec Officer | Aug 20, 2017 | Option Exercise | $12.28 | 12,917 | 158,621 | 1,035,967 | Aug 22, 2017, 04:37 PM |
dEsparbes Eric | SVP and CFO | Aug 20, 2017 | Option Exercise | $12.28 | 5,770 | 70,856 | 344,993 | Aug 22, 2017, 04:37 PM |
dEsparbes Eric | SVP and CFO | Aug 21, 2017 | Sale | $12.20 | 1,825 | 22,265 | 343,168 | Aug 22, 2017, 04:37 PM |
Faerm Michael E. | Sr VP & Chief Business Officer | Aug 20, 2017 | Option Exercise | $12.28 | 3,179 | 39,038 | 283,892 | Aug 22, 2017, 04:35 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Aug 20, 2017 | Option Exercise | $12.28 | 2,596 | 31,879 | 241,557 | Aug 22, 2017, 04:34 PM |
Faerm Michael E. | Sr VP & Chief Business Officer | May 20, 2017 | Option Exercise | $11.86 | 3,176 | 37,667 | 287,071 | May 23, 2017, 04:17 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | May 20, 2017 | Option Exercise | $11.86 | 2,590 | 30,717 | 251,968 | May 23, 2017, 04:16 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | May 22, 2017 | Sale | $12.01 | 7,815 | 93,858 | 244,153 | May 23, 2017, 04:16 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | May 20, 2017 | Option Exercise | $11.86 | 2,228 | 26,424 | 270,110 | May 23, 2017, 04:15 PM |
dEsparbes Eric | SVP and CFO | May 20, 2017 | Option Exercise | $11.86 | 4,208 | 49,907 | 352,588 | May 23, 2017, 04:15 PM |
dEsparbes Eric | SVP and CFO | May 22, 2017 | Sale | $11.85 | 1,825 | 21,626 | 350,763 | May 23, 2017, 04:15 PM |
Aguiar Michael W | President & Chief Exec Officer | May 20, 2017 | Option Exercise | $11.86 | 12,897 | 152,958 | 1,048,884 | May 23, 2017, 04:14 PM |
Aguiar Michael W | President & Chief Exec Officer | Feb 20, 2017 | Option Exercise | $12.04 | 19,429 | 233,925 | 1,059,281 | Feb 22, 2017, 04:31 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Feb 20, 2017 | Option Exercise | $12.04 | 5,355 | 64,474 | 269,838 | Feb 22, 2017, 04:31 PM |
dEsparbes Eric | SVP and CFO | Feb 20, 2017 | Option Exercise | $12.04 | 8,604 | 103,592 | 356,121 | Feb 22, 2017, 04:30 PM |
dEsparbes Eric | SVP and CFO | Feb 21, 2017 | Sale | $12.07 | 1,825 | 22,028 | 354,296 | Feb 22, 2017, 04:30 PM |
Faerm Michael E. | Sr VP & Chief Business Officer | Feb 20, 2017 | Option Exercise | $12.04 | 5,860 | 70,554 | 287,747 | Feb 22, 2017, 04:29 PM |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | Feb 20, 2017 | Option Exercise | $12.04 | 6,367 | 76,659 | 253,782 | Feb 22, 2017, 04:28 PM |
dEsparbes Eric | SVP and CFO | Nov 20, 2016 | Option Exercise | $10.91 | 3,832 | 41,807 | 233,127 | Nov 22, 2016, 05:45 PM |
dEsparbes Eric | SVP and CFO | Nov 21, 2016 | Sale | $10.89 | 1,800 | 19,602 | 231,327 | Nov 22, 2016, 05:45 PM |
Faerm Michael E. | Sr VP & Chief Business Officer | Nov 20, 2016 | Option Exercise | $10.91 | 2,893 | 31,563 | 160,209 | Nov 22, 2016, 05:43 PM |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | Nov 20, 2016 | Option Exercise | $10.91 | 1,487 | 16,223 | 157,131 | Nov 22, 2016, 05:40 PM |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | Nov 22, 2016 | Sale | $10.84 | 3,700 | 40,123 | 153,431 | Nov 22, 2016, 05:40 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Nov 20, 2016 | Option Exercise | $10.91 | 1,273 | 13,888 | 168,475 | Nov 22, 2016, 05:39 PM |
Aguiar Michael W | President & Chief Exec Officer | Nov 20, 2016 | Option Exercise | $10.91 | 8,417 | 91,829 | 745,215 | Nov 22, 2016, 05:28 PM |
Aguiar Michael W | President & Chief Exec Officer | Aug 20, 2016 | Option Exercise | $11.79 | 8,467 | 99,826 | 690,212 | Aug 23, 2016, 06:58 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Aug 20, 2016 | Option Exercise | $11.79 | 1,939 | 22,861 | 169,463 | Aug 23, 2016, 06:57 PM |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | Aug 20, 2016 | Option Exercise | $11.79 | 1,501 | 17,697 | 157,917 | Aug 23, 2016, 06:57 PM |
Faerm Michael E. | Sr VP & Chief Business Officer | Aug 20, 2016 | Option Exercise | $11.79 | 9,544 | 112,524 | 162,870 | Aug 23, 2016, 06:56 PM |
dEsparbes Eric | SVP and CFO | Aug 20, 2016 | Option Exercise | $11.79 | 2,845 | 33,543 | 239,893 | Aug 23, 2016, 06:56 PM |
dEsparbes Eric | SVP and CFO | Aug 22, 2016 | Sale | $11.77 | 3,700 | 43,549 | 236,193 | Aug 23, 2016, 06:56 PM |
dEsparbes Eric | SVP and CFO | May 20, 2016 | Option Exercise | $11.09 | 2,818 | 31,252 | 242,738 | May 20, 2016, 07:52 PM |
Aguiar Michael W | President & Chief Exec Officer | May 20, 2016 | Option Exercise | $11.09 | 8,428 | 93,467 | 698,679 | May 20, 2016, 07:52 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | May 20, 2016 | Option Exercise | $11.09 | 1,276 | 14,151 | 171,402 | May 20, 2016, 07:51 PM |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | May 20, 2016 | Option Exercise | $11.09 | 1,490 | 16,524 | 159,418 | May 20, 2016, 07:50 PM |
Tyree James L | Director | May 18, 2016 | Sale | $10.47 | 813 | 8,512 | 50,697 | May 20, 2016, 07:50 PM |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | Feb 19, 2016 | Option Exercise | $12.28 | 6,486 | 79,648 | 159,068 | Feb 23, 2016, 06:58 PM |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | Feb 19, 2016 | Option Exercise | $12.28 | 5,376 | 66,017 | 170,178 | Feb 23, 2016, 06:57 PM |
Aguiar Michael W | President & Chief Exec Officer | Feb 19, 2016 | Option Exercise | $12.28 | 18,659 | 229,133 | 704,607 | Feb 23, 2016, 06:57 PM |
dEsparbes Eric | SVP and CFO | Feb 19, 2016 | Option Exercise | $12.28 | 5,457 | 67,012 | 243,056 | Feb 23, 2016, 06:56 PM |
dEsparbes Eric | SVP and CFO | Nov 20, 2015 | Option Exercise | $8.92 | 7,940 | 70,825 | 132,779 | Nov 23, 2015, 06:14 AM |
GLAXOSMITHKLINE PLC | 10% Owner | Aug 07, 2015 | Buy | $3485840.00 | 245,828 | 856,917,075,520 | 32,005,260 | Aug 07, 2015, 04:18 PM |
Aguiar Michael W | President & CEO | Jun 02, 2015 | Option Exercise | $16.68 | 24,698 | 411,963 | 432,653 | Jun 04, 2015, 04:12 PM |
Tyree James L | Director | Jun 02, 2015 | Sale | $16.85 | 2,438 | 41,080 | 33,182 | Jun 04, 2015, 04:12 PM |
WALTRIP WILLIAM H | Director | May 27, 2015 | Option Exercise | $13.45 | 16,313 | 219,410 | 139,917 | May 29, 2015, 04:26 PM |
WALTRIP WILLIAM H | Director | May 27, 2015 | Sale | $16.32 | 16,313 | 266,228 | 123,604 | May 29, 2015, 04:26 PM |
Aguiar Michael W | President & CEO | May 20, 2015 | Option Exercise | $16.24 | 3,256 | 52,877 | 457,351 | May 22, 2015, 05:53 PM |
Aguiar Michael W | President & CEO | Feb 20, 2015 | Option Exercise | $18.22 | 6,789 | 123,696 | 458,107 | May 22, 2015, 05:49 PM |
GLAXOSMITHKLINE PLC | 10% Owner | May 11, 2015 | Buy | $1369260.00 | 85,579 | 117,179,901,540 | 31,759,432 | May 11, 2015, 03:40 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Mar 02, 2015 | Buy | $1673690.00 | 92,674 | 155,107,547,060 | 31,673,853 | Mar 02, 2015, 03:45 PM |
Aguiar Michael W | President & CEO | Feb 20, 2015 | Option Exercise | $18.22 | 6,789 | 123,696 | 446,148 | Feb 24, 2015, 06:22 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Nov 04, 2014 | Buy | $12786500.00 | 832,456 | 10,644,198,644,000 | 31,581,179 | Nov 04, 2014, 01:50 PM |
LEE JUNNING | Sr. VP, Technical Operations | Aug 20, 2014 | Option Exercise | $22.76 | 3,261 | 74,220 | 262,198 | Aug 22, 2014, 05:03 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Aug 20, 2014 | Option Exercise | $22.76 | 3,261 | 74,220 | 334,040 | Aug 22, 2014, 05:02 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 20, 2014 | Option Exercise | $22.76 | 3,261 | 74,220 | 443,013 | Aug 22, 2014, 05:01 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Aug 20, 2014 | Option Exercise | $22.76 | 3,261 | 74,220 | 401,538 | Aug 22, 2014, 05:00 PM |
LEE JUNNING | Sr. VP, Technical Operations | Aug 13, 2014 | Option Exercise | $12.44 | 74,441 | 926,264 | 318,883 | Aug 15, 2014, 07:00 PM |
LEE JUNNING | Sr. VP, Technical Operations | Aug 13, 2014 | Sale | $22.50 | 53,424 | 1,202,040 | 265,459 | Aug 15, 2014, 07:00 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 11, 2014 | Option Exercise | $14.53 | 33,667 | 489,182 | 474,430 | Aug 13, 2014, 07:02 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 12, 2014 | Sale | $22.30 | 1,048 | 23,370 | 446,274 | Aug 13, 2014, 07:02 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 11, 2014 | Sale | $22.12 | 27,108 | 599,629 | 447,322 | Aug 13, 2014, 07:02 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Aug 11, 2014 | Buy | $3912270.00 | 172,651 | 675,457,327,770 | 30,748,723 | Aug 11, 2014, 04:55 PM |
GLAXOSMITHKLINE PLC | 10% Owner | May 09, 2014 | Buy | $8544840.00 | 317,770 | 2,715,293,806,800 | 30,576,072 | May 13, 2014, 04:43 PM |
Winningham Rick E | Chief Executive Officer | May 09, 2014 | Option Exercise | $26.86 | 50,225 | 1,349,044 | 703,038 | May 12, 2014, 07:14 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | May 09, 2014 | Option Exercise | $26.86 | 22,833 | 613,294 | 341,398 | May 12, 2014, 07:14 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | May 09, 2014 | Option Exercise | $26.86 | 22,833 | 613,294 | 239,136 | May 12, 2014, 07:13 PM |
LEE JUNNING | Sr. VP, Technical Operations | May 09, 2014 | Option Exercise | $26.86 | 14,650 | 393,499 | 159,887 | May 12, 2014, 07:11 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | May 09, 2014 | Option Exercise | $26.86 | 18,849 | 506,284 | 305,434 | May 12, 2014, 07:10 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | May 09, 2014 | Option Exercise | $26.86 | 21,405 | 574,938 | 145,570 | May 12, 2014, 07:09 PM |
Gunderson Robert V JR | Director | Apr 17, 2014 | Option Exercise | $9.69 | 25,806 | 249,996 | 109,970 | Apr 21, 2014, 07:03 PM |
YOUNG WILLIAM D | Director | Apr 07, 2014 | Option Exercise | $9.69 | 25,806 | 249,996 | 77,935 | Apr 09, 2014, 07:07 PM |
WALTRIP WILLIAM H | Director | Mar 31, 2014 | Option Exercise | $9.69 | 25,806 | 249,996 | 94,064 | Apr 02, 2014, 04:18 PM |
LEVINE ARNOLD J | Director | Mar 21, 2014 | Option Exercise | $9.69 | 25,806 | 249,996 | 111,794 | Mar 25, 2014, 07:39 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Mar 06, 2014 | Option Exercise | $14.90 | 42,153 | 627,997 | 224,469 | Mar 10, 2014, 07:06 PM |
WHITESIDES GEORGE M | Director | Mar 06, 2014 | Option Exercise | $9.69 | 25,806 | 249,996 | 600,377 | Mar 10, 2014, 07:05 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Mar 03, 2014 | Option Exercise | $9.69 | 96,773 | 937,488 | 392,537 | Mar 05, 2014, 07:05 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Mar 03, 2014 | Sale | $36.73 | 65,806 | 2,417,314 | 328,531 | Mar 05, 2014, 07:05 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2014 | Option Exercise | $39.98 | 9,297 | 371,694 | 670,763 | Feb 24, 2014, 07:12 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2014 | Option Exercise | $39.98 | 4,310 | 172,314 | 295,764 | Feb 24, 2014, 07:11 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Feb 20, 2014 | Option Exercise | $39.98 | 4,307 | 172,194 | 182,316 | Feb 24, 2014, 07:11 PM |
LEE JUNNING | Sr. VP, Technical Operations | Feb 20, 2014 | Option Exercise | $39.98 | 3,854 | 154,083 | 148,287 | Feb 24, 2014, 07:10 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Feb 20, 2014 | Option Exercise | $39.98 | 4,311 | 172,354 | 286,783 | Feb 24, 2014, 07:10 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Feb 20, 2014 | Option Exercise | $39.98 | 4,302 | 171,994 | 129,475 | Feb 24, 2014, 07:09 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Feb 14, 2014 | Sale | $39.36 | 35,000 | 1,377,688 | 191,223 | Feb 19, 2014, 07:13 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Feb 11, 2014 | Buy | $12850700.00 | 342,229 | 4,397,882,210,300 | 30,258,302 | Feb 13, 2014, 04:41 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2013 | Option Exercise | $36.40 | 10,046 | 365,674 | 680,060 | Nov 22, 2013, 07:03 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 20, 2013 | Option Exercise | $36.40 | 4,569 | 166,312 | 300,074 | Nov 22, 2013, 07:02 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Nov 20, 2013 | Option Exercise | $36.40 | 4,569 | 166,312 | 222,073 | Nov 22, 2013, 07:02 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Nov 20, 2013 | Option Exercise | $36.40 | 4,569 | 166,312 | 133,777 | Nov 22, 2013, 07:01 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Oct 29, 2013 | Buy | $4913610.00 | 130,473 | 641,093,437,530 | 29,916,073 | Oct 29, 2013, 05:37 PM |
Winningham Rick E | Chief Executive Officer | Sep 12, 2013 | Sale | $40.03 | 22,353 | 894,791 | 690,106 | Sep 13, 2013, 07:02 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2013 | Option Exercise | $35.89 | 10,046 | 360,551 | 712,459 | Aug 22, 2013, 07:03 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 20, 2013 | Option Exercise | $35.89 | 3,773 | 135,413 | 304,643 | Aug 22, 2013, 07:03 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Aug 20, 2013 | Option Exercise | $35.89 | 3,813 | 136,849 | 207,892 | Aug 22, 2013, 07:02 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Aug 21, 2013 | Option Exercise | $16.00 | 18,750 | 300,000 | 226,642 | Aug 22, 2013, 07:02 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 20, 2013 | Option Exercise | $35.89 | 4,570 | 164,017 | 138,346 | Aug 22, 2013, 07:01 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Jul 30, 2013 | Sale | $36.51 | 7,000 | 255,570 | 211,705 | Aug 01, 2013, 05:33 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Jul 30, 2013 | Buy | $111851000.00 | 3,064,407 | 342,756,987,357,000 | 29,785,600 | Aug 01, 2013, 09:23 AM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Jun 07, 2013 | Sale | $35.04 | 31,038 | 1,087,572 | 303,416 | Jun 11, 2013, 07:02 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | May 29, 2013 | Option Exercise | $8.54 | 11,021 | 94,159 | 213,705 | May 31, 2013, 07:03 PM |
Brinkley David L | Head of Business Dev. | May 29, 2013 | Sale | $35.01 | 3,808 | 133,318 | 48,749 | May 31, 2013, 07:02 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2013 | Option Exercise | $37.01 | 10,046 | 371,802 | 711,505 | May 22, 2013, 06:56 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | May 20, 2013 | Option Exercise | $37.01 | 3,292 | 121,837 | 334,454 | May 22, 2013, 06:56 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | May 20, 2013 | Option Exercise | $37.01 | 3,292 | 121,837 | 202,684 | May 22, 2013, 06:55 PM |
Brinkley David L | Head of Business Dev. | May 20, 2013 | Option Exercise | $37.01 | 2,443 | 90,415 | 52,557 | May 22, 2013, 06:55 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | May 20, 2013 | Option Exercise | $37.01 | 3,292 | 121,837 | 286,094 | May 22, 2013, 06:54 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | May 20, 2013 | Option Exercise | $37.01 | 4,570 | 169,136 | 137,916 | May 22, 2013, 06:54 PM |
Brinkley David L | Head of Business Dev. | May 13, 2013 | Option Exercise | $34.00 | 16,129 | 548,386 | 71,129 | May 15, 2013, 07:07 PM |
Brinkley David L | Head of Business Dev. | May 13, 2013 | Sale | $40.33 | 16,129 | 650,483 | 55,000 | May 15, 2013, 07:07 PM |
Brinkley David L | Head of Business Dev. | May 03, 2013 | Option Exercise | $29.65 | 16,129 | 478,225 | 71,129 | May 07, 2013, 07:01 PM |
Brinkley David L | Head of Business Dev. | May 03, 2013 | Sale | $34.77 | 16,129 | 560,805 | 55,000 | May 07, 2013, 07:01 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Apr 30, 2013 | Sale | $33.74 | 7,000 | 236,164 | 206,176 | May 02, 2013, 07:06 PM |
Brinkley David L | Head of Business Dev. | Apr 30, 2013 | Option Exercise | $6.15 | 8,333 | 51,248 | 72,104 | May 02, 2013, 07:05 PM |
Brinkley David L | Head of Business Dev. | Apr 30, 2013 | Sale | $33.76 | 17,104 | 577,490 | 55,100 | May 02, 2013, 07:05 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Apr 30, 2013 | Option Exercise | $17.91 | 170,879 | 3,060,443 | 313,365 | May 02, 2013, 07:04 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Apr 30, 2013 | Sale | $33.80 | 170,879 | 5,776,341 | 152,586 | May 02, 2013, 07:04 PM |
Winningham Rick E | Chief Executive Officer | Apr 30, 2013 | Option Exercise | $9.69 | 385,161 | 3,731,247 | 977,083 | May 02, 2013, 07:00 PM |
Winningham Rick E | Chief Executive Officer | Apr 30, 2013 | Sale | $33.64 | 255,532 | 8,597,169 | 723,128 | May 02, 2013, 07:00 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Apr 30, 2013 | Buy | $6699220.00 | 193,563 | 1,296,721,120,860 | 26,721,193 | Apr 30, 2013, 02:38 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2013 | Option Exercise | $22.10 | 10,655 | 235,476 | 591,922 | Feb 22, 2013, 07:05 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2013 | Option Exercise | $22.10 | 5,004 | 110,588 | 337,746 | Feb 22, 2013, 07:04 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Feb 20, 2013 | Option Exercise | $22.10 | 5,002 | 110,544 | 219,976 | Feb 22, 2013, 07:03 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Feb 20, 2013 | Sale | $22.14 | 7,000 | 154,980 | 212,976 | Feb 22, 2013, 07:03 PM |
Brinkley David L | Head of Business Dev. | Feb 20, 2013 | Option Exercise | $22.10 | 3,416 | 75,494 | 63,771 | Feb 22, 2013, 07:03 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Feb 15, 2013 | Buy | $2567090.00 | 116,527 | 299,135,296,430 | 26,527,630 | Feb 20, 2013, 03:04 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Jan 11, 2013 | Option Exercise | $3.10 | 14,510 | 44,981 | 220,438 | Jan 14, 2013, 07:04 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 20, 2012 | Option Exercise | $21.08 | 4,874 | 102,744 | 337,750 | Nov 20, 2012, 07:06 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Nov 20, 2012 | Option Exercise | $21.08 | 4,874 | 102,744 | 205,928 | Nov 20, 2012, 07:05 PM |
Brinkley David L | Head of Business Dev. | Nov 20, 2012 | Option Exercise | $21.08 | 3,054 | 64,378 | 62,187 | Nov 20, 2012, 07:03 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Nov 14, 2012 | Option Exercise | $3.10 | 5,161 | 15,999 | 210,802 | Nov 16, 2012, 07:01 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Nov 02, 2012 | Sale | $21.45 | 7,000 | 150,162 | 205,841 | Nov 06, 2012, 07:01 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Nov 02, 2012 | Buy | $6265780.00 | 280,348 | 1,756,598,891,440 | 26,411,103 | Nov 05, 2012, 01:38 PM |
Brinkley David L | Head of Business Dev. | Aug 24, 2012 | Sale | $27.50 | 3,483 | 95,783 | 60,241 | Aug 28, 2012, 07:02 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 24, 2012 | Option Exercise | $17.91 | 4,121 | 73,807 | 157,168 | Aug 28, 2012, 07:01 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 27, 2012 | Sale | $27.33 | 20,561 | 561,855 | 135,347 | Aug 28, 2012, 07:01 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 24, 2012 | Sale | $28.01 | 4,121 | 115,429 | 153,047 | Aug 28, 2012, 07:01 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2012 | Option Exercise | $27.01 | 10,681 | 288,494 | 580,577 | Aug 22, 2012, 07:05 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 20, 2012 | Option Exercise | $27.01 | 4,596 | 124,138 | 337,624 | Aug 22, 2012, 07:04 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Aug 20, 2012 | Option Exercise | $27.01 | 4,644 | 125,434 | 207,641 | Aug 22, 2012, 07:03 PM |
Brinkley David L | Head of Business Dev. | Aug 20, 2012 | Option Exercise | $27.01 | 3,057 | 82,570 | 63,724 | Aug 22, 2012, 07:02 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 20, 2012 | Option Exercise | $27.01 | 4,877 | 131,728 | 153,047 | Aug 22, 2012, 07:01 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Aug 13, 2012 | Sale | $25.74 | 25,000 | 643,461 | 215,393 | Aug 15, 2012, 07:05 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 07, 2012 | Option Exercise | $16.25 | 60,000 | 975,000 | 217,924 | Aug 09, 2012, 07:00 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 07, 2012 | Sale | $27.04 | 60,000 | 1,622,400 | 157,924 | Aug 09, 2012, 07:00 PM |
Brinkley David L | Head of Business Dev. | Aug 03, 2012 | Option Exercise | $7.88 | 106,757 | 840,955 | 190,698 | Aug 07, 2012, 07:03 PM |
Brinkley David L | Head of Business Dev. | Aug 03, 2012 | Sale | $27.92 | 123,917 | 3,459,763 | 66,781 | Aug 07, 2012, 07:03 PM |
Winningham Rick E | Chief Executive Officer | Aug 03, 2012 | Option Exercise | $3.10 | 145,161 | 449,999 | 667,007 | Aug 07, 2012, 07:02 PM |
Winningham Rick E | Chief Executive Officer | Aug 03, 2012 | Sale | $27.95 | 75,749 | 2,117,306 | 627,458 | Aug 07, 2012, 07:02 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Aug 03, 2012 | Buy | $28.21 | 316,334 | 8,923,782 | 26,130,755 | Aug 07, 2012, 12:54 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Jul 30, 2012 | Option Exercise | $29.69 | 7,546 | 224,041 | 279,386 | Aug 01, 2012, 07:00 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | May 29, 2012 | Sale | $22.29 | 20,000 | 445,800 | 157,924 | May 31, 2012, 07:27 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | May 20, 2012 | Option Exercise | $20.33 | 3,832 | 77,905 | 342,220 | May 22, 2012, 07:23 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | May 20, 2012 | Option Exercise | $20.33 | 3,832 | 77,905 | 237,285 | May 22, 2012, 07:21 PM |
Brinkley David L | Head of Business Dev. | May 20, 2012 | Option Exercise | $20.33 | 2,402 | 48,833 | 83,941 | May 22, 2012, 07:21 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | May 20, 2012 | Option Exercise | $20.33 | 3,832 | 77,905 | 177,924 | May 22, 2012, 07:20 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2012 | Option Exercise | $20.33 | 10,681 | 217,145 | 521,846 | May 22, 2012, 07:20 PM |
GLAXOSMITHKLINE PLC | 10% Owner | May 16, 2012 | Buy | $21.29 | 10,000,000 | 212,887,001 | 25,814,421 | May 16, 2012, 09:29 AM |
Winningham Rick E | Chief Executive Officer | May 04, 2012 | Option Exercise | $6.33 | 63,225 | 400,070 | 532,527 | May 04, 2012, 05:41 PM |
DRAZAN JEFFREY M | Director | May 01, 2012 | Sale | $21.71 | 8,586 | 186,402 | 33,465 | May 02, 2012, 07:01 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2012 | Option Exercise | $18.54 | 9,621 | 178,373 | 346,052 | Feb 22, 2012, 07:03 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Feb 20, 2012 | Option Exercise | $18.54 | 9,747 | 180,709 | 241,117 | Feb 22, 2012, 07:03 PM |
Brinkley David L | Head of Business Dev. | Feb 20, 2012 | Option Exercise | $18.54 | 5,318 | 98,596 | 86,343 | Feb 22, 2012, 07:01 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Feb 20, 2012 | Option Exercise | $18.54 | 10,018 | 185,734 | 181,756 | Feb 22, 2012, 07:01 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2012 | Option Exercise | $18.54 | 21,386 | 396,496 | 469,302 | Feb 22, 2012, 07:00 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Feb 14, 2012 | Buy | $18.12 | 88,468 | 1,603,040 | 15,814,421 | Feb 14, 2012, 12:57 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Dec 09, 2011 | Sale | $21.86 | 10,000 | 218,600 | 186,774 | Dec 13, 2011, 07:02 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 28, 2011 | Option Exercise | $8.53 | 30,205 | 257,649 | 370,673 | Nov 30, 2011, 07:44 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 28, 2011 | Sale | $21.00 | 20,000 | 420,000 | 350,673 | Nov 30, 2011, 07:44 PM |
DRAZAN JEFFREY M | Director | Nov 28, 2011 | Sale | $21.00 | 4,293 | 90,153 | 42,051 | Nov 30, 2011, 07:43 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 20, 2011 | Option Exercise | $22.34 | 2,121 | 47,383 | 340,468 | Nov 22, 2011, 07:06 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Nov 20, 2011 | Option Exercise | $22.34 | 2,250 | 50,265 | 245,864 | Nov 22, 2011, 07:05 PM |
Brinkley David L | Head of Business Dev. | Nov 20, 2011 | Option Exercise | $22.34 | 1,887 | 42,156 | 86,661 | Nov 22, 2011, 07:04 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Nov 20, 2011 | Option Exercise | $22.34 | 2,532 | 56,565 | 196,774 | Nov 22, 2011, 07:03 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2011 | Option Exercise | $22.34 | 6,218 | 138,910 | 479,688 | Nov 22, 2011, 07:03 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Nov 01, 2011 | Buy | $22.23 | 58,411 | 1,298,477 | 15,725,953 | Nov 03, 2011, 02:25 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Sep 01, 2011 | Option Exercise | $8.52 | 3,225 | 27,493 | 248,114 | Sep 02, 2011, 06:02 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 20, 2011 | Option Exercise | $17.50 | 2,120 | 37,100 | 342,589 | Aug 24, 2011, 04:24 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Aug 20, 2011 | Option Exercise | $17.50 | 2,248 | 39,340 | 244,889 | Aug 24, 2011, 04:23 PM |
Brinkley David L | Head of Business Dev. | Aug 20, 2011 | Option Exercise | $17.50 | 1,889 | 33,058 | 88,548 | Aug 24, 2011, 04:22 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 20, 2011 | Option Exercise | $17.50 | 2,532 | 44,310 | 199,306 | Aug 24, 2011, 04:21 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Aug 02, 2011 | Buy | $19.71 | 102,466 | 2,019,605 | 15,667,542 | Aug 03, 2011, 01:43 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Jun 14, 2011 | Sale | $22.94 | 14,225 | 326,322 | 201,838 | Jun 16, 2011, 07:00 PM |
DRAZAN JEFFREY M | Director | Jun 06, 2011 | Sale | $23.08 | 37,344 | 861,900 | 78,251 | Jun 08, 2011, 07:45 PM |
DRAZAN JEFFREY M | Director | Jun 07, 2011 | Sale | $23.29 | 31,907 | 743,114 | 46,344 | Jun 08, 2011, 07:45 PM |
Brinkley David L | Head of Business Dev. | May 31, 2011 | Option Exercise | $9.89 | 45,441 | 449,342 | 141,937 | Jun 01, 2011, 07:00 PM |
Brinkley David L | Head of Business Dev. | May 27, 2011 | Option Exercise | $9.07 | 57,812 | 524,342 | 154,308 | Jun 01, 2011, 07:00 PM |
Brinkley David L | Head of Business Dev. | May 31, 2011 | Sale | $25.65 | 51,500 | 1,320,975 | 90,437 | Jun 01, 2011, 07:00 PM |
Brinkley David L | Head of Business Dev. | May 27, 2011 | Sale | $25.31 | 57,812 | 1,463,222 | 96,496 | Jun 01, 2011, 07:00 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | May 20, 2011 | Option Exercise | $25.48 | 2,116 | 53,916 | 344,709 | May 24, 2011, 07:10 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | May 20, 2011 | Option Exercise | $25.48 | 2,245 | 57,203 | 247,137 | May 24, 2011, 07:08 PM |
Brinkley David L | Head of Business Dev. | May 20, 2011 | Option Exercise | $25.48 | 1,883 | 47,979 | 96,496 | May 24, 2011, 07:06 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | May 20, 2011 | Option Exercise | $25.48 | 2,527 | 64,388 | 216,063 | May 24, 2011, 07:03 PM |
Winningham Rick E | Chief Executive Officer | May 11, 2011 | Sale | $26.28 | 73,100 | 1,921,068 | 485,906 | May 12, 2011, 07:01 PM |
Winningham Rick E | Chief Executive Officer | May 10, 2011 | Sale | $26.41 | 54,646 | 1,443,201 | 559,006 | May 12, 2011, 07:01 PM |
GLAXOSMITHKLINE PLC | 10% Owner | May 03, 2011 | Buy | $25.60 | 261,299 | 6,689,254 | 6,163,577 | May 04, 2011, 12:26 PM |
Brinkley David L | Head of Business Dev. | Mar 16, 2011 | Option Exercise | $3.10 | 2,100 | 6,510 | 100,479 | Mar 17, 2011, 07:10 PM |
Brinkley David L | Head of Business Dev. | Mar 15, 2011 | Option Exercise | $7.67 | 45,492 | 348,837 | 143,871 | Mar 17, 2011, 07:10 PM |
Brinkley David L | Head of Business Dev. | Mar 15, 2011 | Sale | $22.08 | 45,492 | 1,004,463 | 98,379 | Mar 17, 2011, 07:10 PM |
Brinkley David L | Head of Business Dev. | Mar 16, 2011 | Sale | $22.02 | 2,100 | 46,242 | 98,379 | Mar 17, 2011, 07:10 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Mar 11, 2011 | Sale | $22.75 | 6,451 | 146,760 | 0 | Mar 15, 2011, 07:05 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Mar 11, 2011 | Sale | $22.76 | 20,238 | 460,617 | 346,825 | Mar 15, 2011, 07:05 PM |
YOUNG WILLIAM D | Director | Mar 07, 2011 | Option Exercise | $8.52 | 10,752 | 91,661 | 39,505 | Mar 09, 2011, 07:00 PM |
YOUNG WILLIAM D | Director | Mar 07, 2011 | Sale | $22.31 | 5,376 | 119,939 | 34,129 | Mar 09, 2011, 07:00 PM |
Winningham Rick E | Chief Executive Officer | Mar 01, 2011 | Sale | $22.53 | 63,873 | 1,439,059 | 613,652 | Mar 03, 2011, 07:02 PM |
Winningham Rick E | Chief Executive Officer | Feb 24, 2011 | Option Exercise | $8.52 | 135,950 | 1,158,974 | 692,223 | Feb 28, 2011, 07:35 PM |
Winningham Rick E | Chief Executive Officer | Feb 28, 2011 | Option Exercise | $8.52 | 101,752 | 867,436 | 744,525 | Feb 28, 2011, 07:35 PM |
Winningham Rick E | Chief Executive Officer | Feb 25, 2011 | Option Exercise | $8.52 | 135,850 | 1,158,121 | 734,973 | Feb 28, 2011, 07:35 PM |
Winningham Rick E | Chief Executive Officer | Feb 28, 2011 | Sale | $23.05 | 67,000 | 1,544,030 | 714,725 | Feb 28, 2011, 07:35 PM |
Winningham Rick E | Chief Executive Officer | Feb 25, 2011 | Sale | $22.46 | 92,200 | 2,070,524 | 684,773 | Feb 28, 2011, 07:35 PM |
Winningham Rick E | Chief Executive Officer | Feb 24, 2011 | Sale | $21.45 | 93,100 | 1,996,995 | 599,123 | Feb 28, 2011, 07:35 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2011 | Option Exercise | $22.50 | 3,111 | 69,998 | 367,063 | Feb 23, 2011, 07:11 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Feb 20, 2011 | Option Exercise | $22.50 | 3,240 | 72,900 | 249,382 | Feb 23, 2011, 07:11 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Feb 18, 2011 | Sale | $23.12 | 3,701 | 85,567 | 252,622 | Feb 23, 2011, 07:11 PM |
Brinkley David L | Head of Business Dev. | Feb 20, 2011 | Option Exercise | $22.50 | 2,480 | 55,800 | 98,379 | Feb 23, 2011, 07:09 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Feb 20, 2011 | Option Exercise | $22.50 | 3,511 | 78,998 | 218,590 | Feb 23, 2011, 07:08 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2011 | Option Exercise | $22.50 | 6,790 | 152,775 | 422,033 | Feb 23, 2011, 07:08 PM |
Winningham Rick E | Chief Executive Officer | Feb 23, 2011 | Option Exercise | $8.52 | 142,500 | 1,214,812 | 653,873 | Feb 23, 2011, 07:08 PM |
Winningham Rick E | Chief Executive Officer | Feb 22, 2011 | Option Exercise | $8.52 | 258,140 | 2,200,643 | 680,173 | Feb 23, 2011, 07:08 PM |
Winningham Rick E | Chief Executive Officer | Feb 23, 2011 | Sale | $21.14 | 97,600 | 2,063,264 | 556,273 | Feb 23, 2011, 07:08 PM |
Winningham Rick E | Chief Executive Officer | Feb 22, 2011 | Sale | $21.47 | 168,800 | 3,624,800 | 521,673 | Feb 23, 2011, 07:08 PM |
YOUNG WILLIAM D | Director | Feb 18, 2011 | Option Exercise | $8.52 | 10,752 | 91,661 | 34,129 | Feb 23, 2011, 07:04 PM |
YOUNG WILLIAM D | Director | Feb 18, 2011 | Sale | $23.22 | 5,376 | 124,831 | 28,753 | Feb 23, 2011, 07:04 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Feb 18, 2011 | Buy | $23.70 | 152,278 | 3,608,989 | 5,902,278 | Feb 22, 2011, 12:07 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Jan 28, 2011 | Option Exercise | $8.52 | 9,838 | 83,869 | 143,823 | Jan 28, 2011, 07:01 PM |
YOUNG WILLIAM D | Director | Dec 10, 2010 | Option Exercise | $8.52 | 10,754 | 91,678 | 28,754 | Dec 13, 2010, 07:06 PM |
YOUNG WILLIAM D | Director | Dec 10, 2010 | Sale | $26.64 | 5,377 | 143,243 | 23,377 | Dec 13, 2010, 07:06 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Dec 03, 2010 | Sale | $26.51 | 10,000 | 265,100 | 109,601 | Dec 03, 2010, 07:16 PM |
Brinkley David L | Head of Business Dev. | Dec 01, 2010 | Option Exercise | $3.10 | 15,275 | 47,352 | 58,359 | Dec 03, 2010, 07:15 PM |
Brinkley David L | Head of Business Dev. | Dec 01, 2010 | Sale | $25.07 | 20,000 | 501,400 | 38,359 | Dec 03, 2010, 07:15 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Nov 29, 2010 | Buy | $22.50 | 5,750,000 | 129,375,000 | 5,750,000 | Nov 30, 2010, 12:13 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 20, 2010 | Option Exercise | $22.52 | 2,403 | 54,116 | 257,674 | Nov 23, 2010, 07:01 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Nov 20, 2010 | Option Exercise | $22.52 | 2,532 | 57,021 | 133,985 | Nov 23, 2010, 07:01 PM |
Brinkley David L | Head of Business Dev. | Nov 20, 2010 | Option Exercise | $22.52 | 1,767 | 39,793 | 43,084 | Nov 23, 2010, 07:01 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Nov 20, 2010 | Option Exercise | $22.52 | 2,814 | 63,371 | 119,601 | Nov 23, 2010, 07:00 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2010 | Option Exercise | $22.52 | 5,555 | 125,099 | 181,323 | Nov 23, 2010, 07:00 PM |
Brinkley David L | Head of Business Dev. | Sep 14, 2010 | Sale | $15.12 | 1,980 | 29,938 | 32,351 | Sep 16, 2010, 07:03 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Sep 07, 2010 | Option Exercise | $8.52 | 6,451 | 54,995 | 124,017 | Sep 08, 2010, 07:15 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Sep 01, 2010 | Sale | $12.84 | 4,416 | 56,701 | 117,566 | Sep 02, 2010, 07:09 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2010 | Option Exercise | $14.00 | 3,624 | 50,736 | 159,378 | Aug 23, 2010, 07:03 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 20, 2010 | Option Exercise | $14.00 | 1,543 | 21,602 | 247,577 | Aug 23, 2010, 07:02 PM |
Mammen Mathai | SVP, Research & Early Clin Dev | Aug 20, 2010 | Option Exercise | $14.00 | 1,671 | 23,394 | 121,982 | Aug 23, 2010, 07:01 PM |
Brinkley David L | Head of Business Dev. | Aug 20, 2010 | Option Exercise | $14.00 | 907 | 12,698 | 34,331 | Aug 23, 2010, 07:01 PM |
Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 20, 2010 | Option Exercise | $14.00 | 1,955 | 27,370 | 109,915 | Aug 23, 2010, 07:00 PM |
Owner | Relationship | Date | Value($) |
Basso Stephen | Chief Financial Officer | 03/05/2024 | 179,988 |
Ronsheim Matthew | See Remarks | 03/05/2024 | 189,988 |
Zhen Marianne | Chief Accounting Officer | 03/05/2024 | 159,990 |
Ronsheim Matthew | See Remarks | 02/20/2024 | 12,751 |
Zhen Marianne | Chief Accounting Officer | 02/20/2024 | 45,220 |
Ronsheim Matthew | See Remarks | 01/18/2024 | 25,680 |
Zhen Marianne | Chief Accounting Officer | 11/15/2023 | 153,810 |
Zhen Marianne | Chief Accounting Officer | 08/18/2023 | 10,707 |
DENNER ALEXANDER J | 10% Owner | 06/06/2023 | 104,384 |
DENNER ALEXANDER J | 10% Owner | 06/05/2023 | 91,297 |
DENNER ALEXANDER J | 10% Owner | 05/26/2023 | 393,729 |
DENNER ALEXANDER J | 10% Owner | 05/25/2023 | 654,330 |
DENNER ALEXANDER J | 10% Owner | 05/30/2023 | 1,560,648 |
Zhen Marianne | Chief Accounting Officer | 05/19/2023 | 10,560 |
DENNER ALEXANDER J | 10% Owner | 05/19/2023 | 485,147 |
DENNER ALEXANDER J | 10% Owner | 05/18/2023 | 130,538 |
DENNER ALEXANDER J | 10% Owner | 05/17/2023 | 653,690 |
DENNER ALEXANDER J | 10% Owner | 05/17/2023 | 653,690 |
DENNER ALEXANDER J | 10% Owner | 05/18/2023 | 130,538 |
DENNER ALEXANDER J | 10% Owner | 05/11/2023 | 3,577,411 |
Raifeld Pavel | Chief Executive Officer | 03/10/2023 | 32,603 |
Zhen Marianne | Chief Accounting Officer | 02/17/2023 | 23,002 |
Zhen Marianne | Chief Accounting Officer | 11/18/2022 | 11,219 |
Zhen Marianne | Chief Accounting Officer | 08/19/2022 | 11,720 |
Zhen Marianne | Chief Accounting Officer | 05/20/2022 | 13,488 |
Zhen Marianne | Chief Accounting Officer | 02/18/2022 | 45,517 |
Zhen Marianne | Chief Accounting Officer | 11/19/2021 | 12,924 |
Zhen Marianne | Chief Accounting Officer | 08/20/2021 | 17,940 |
Zhen Marianne | Chief Accounting Officer | 08/20/2021 | 12,114 |
Zhen Marianne | Chief Accounting Officer | 08/19/2021 | 44,888 |
Zhen Marianne | Chief Accounting Officer | 08/20/2021 | 17,940 |
Bickerstaff George | Director | 05/24/2021 | 134,619 |
Bickerstaff George | Director | 05/21/2021 | 129,670 |
Zhen Marianne | Chief Accounting Officer | 02/19/2021 | 24,748 |
Zhen Marianne | Chief Accounting Officer | 11/20/2020 | 8,738 |
Zhen Marianne | Chief Accounting Officer | 08/20/2020 | 10,512 |
HULME GEOFFREY | Interim Principal Exec Officer | 05/20/2020 | 4,780 |
Zhen Marianne | Chief Accounting Officer | 05/20/2020 | 12,211 |
HULME GEOFFREY | Interim Principal Exec Officer | 02/20/2020 | 23,390 |
Zhen Marianne | Chief Accounting Officer | 02/20/2020 | 31,302 |
Zhen Marianne | Chief Accounting Officer | 02/24/2020 | 43,660 |
Zhen Marianne | Chief Accounting Officer | 11/20/2019 | 7,579 |
HULME GEOFFREY | Interim PEO | 09/04/2019 | 32,684 |
Zhen Marianne | Chief Accounting Officer | 08/20/2019 | 6,900 |
Zhen Marianne | Chief Accounting Officer | 05/20/2019 | 8,540 |
Bickerstaff George | Director | 02/27/2019 | 238,500 |
Zhen Marianne | Chief Accounting Officer | 02/26/2019 | 89,872 |
Zhen Marianne | Chief Accounting Officer | 02/20/2019 | 19,849 |
Bickerstaff George | Director | 02/21/2019 | 148,958 |
HULME GEOFFREY | Interim PEO | 02/19/2019 | 44,941 |
HULME GEOFFREY | Interim PEO | 02/15/2019 | 103,600 |
Zhen Marianne | Chief Accounting Officer | 11/20/2018 | 8,872 |
Zhen Marianne | Chief Accounting Officer | 08/20/2018 | 7,547 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 08/20/2018 | 79,974 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 08/21/2018 | 112,840 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 08/20/2018 | 43,493 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 08/21/2018 | 120,080 |
dEsparbes Eric | SVP and CFO | 05/20/2018 | 115,276 |
dEsparbes Eric | SVP and CFO | 05/21/2018 | 83,623 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 05/20/2018 | 68,310 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 05/21/2018 | 115,202 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 05/20/2018 | 45,069 |
dEsparbes Eric | Interim PEO, SVP and CFO | 02/20/2018 | 408,961 |
dEsparbes Eric | Interim PEO, SVP and CFO | 02/21/2018 | 88,825 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 02/20/2018 | 254,820 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 02/20/2018 | 274,548 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 02/21/2018 | 132,100 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 02/21/2018 | 164,148 |
Aguiar Michael W | President & Chief Exec Officer | 12/04/2017 | 157,791 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 11/20/2017 | 194,350 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 11/21/2017 | 172,795 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 11/20/2017 | 44,225 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 11/21/2017 | 69,145 |
dEsparbes Eric | SVP and CFO | 11/20/2017 | 80,877 |
dEsparbes Eric | SVP and CFO | 11/21/2017 | 179,171 |
dEsparbes Eric | SVP and CFO | 11/20/2017 | 23,798 |
Aguiar Michael W | President & Chief Exec Officer | 11/20/2017 | 566,810 |
Faerm Michael E. | Sr VP & Chief Business Officer | 11/20/2017 | 58,870 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 08/20/2017 | 35,440 |
Aguiar Michael W | President & Chief Exec Officer | 08/20/2017 | 158,621 |
dEsparbes Eric | SVP and CFO | 08/20/2017 | 70,856 |
dEsparbes Eric | SVP and CFO | 08/21/2017 | 22,265 |
Faerm Michael E. | Sr VP & Chief Business Officer | 08/20/2017 | 39,038 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 08/20/2017 | 31,879 |
Faerm Michael E. | Sr VP & Chief Business Officer | 05/20/2017 | 37,667 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 05/20/2017 | 30,717 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 05/22/2017 | 93,858 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 05/20/2017 | 26,424 |
dEsparbes Eric | SVP and CFO | 05/20/2017 | 49,907 |
dEsparbes Eric | SVP and CFO | 05/22/2017 | 21,626 |
Aguiar Michael W | President & Chief Exec Officer | 05/20/2017 | 152,958 |
Aguiar Michael W | President & Chief Exec Officer | 02/20/2017 | 233,925 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 02/20/2017 | 64,474 |
dEsparbes Eric | SVP and CFO | 02/20/2017 | 103,592 |
dEsparbes Eric | SVP and CFO | 02/21/2017 | 22,028 |
Faerm Michael E. | Sr VP & Chief Business Officer | 02/20/2017 | 70,554 |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 02/20/2017 | 76,659 |
dEsparbes Eric | SVP and CFO | 11/20/2016 | 41,807 |
dEsparbes Eric | SVP and CFO | 11/21/2016 | 19,602 |
Faerm Michael E. | Sr VP & Chief Business Officer | 11/20/2016 | 31,563 |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | 11/20/2016 | 16,223 |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | 11/22/2016 | 40,123 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 11/20/2016 | 13,888 |
Aguiar Michael W | President & Chief Exec Officer | 11/20/2016 | 91,829 |
Aguiar Michael W | President & Chief Exec Officer | 08/20/2016 | 99,826 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 08/20/2016 | 22,861 |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | 08/20/2016 | 17,697 |
Faerm Michael E. | Sr VP & Chief Business Officer | 08/20/2016 | 112,524 |
dEsparbes Eric | SVP and CFO | 08/20/2016 | 33,543 |
dEsparbes Eric | SVP and CFO | 08/22/2016 | 43,549 |
dEsparbes Eric | SVP and CFO | 05/20/2016 | 31,252 |
Aguiar Michael W | President & Chief Exec Officer | 05/20/2016 | 93,467 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 05/20/2016 | 14,151 |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | 05/20/2016 | 16,524 |
Tyree James L | Director | 05/18/2016 | 8,512 |
WITEK THEODORE L JR | Sr. VP & Chief Scientific Off. | 02/19/2016 | 79,648 |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 02/19/2016 | 66,017 |
Aguiar Michael W | President & Chief Exec Officer | 02/19/2016 | 229,133 |
dEsparbes Eric | SVP and CFO | 02/19/2016 | 67,012 |
dEsparbes Eric | SVP and CFO | 11/20/2015 | 70,825 |
GLAXOSMITHKLINE PLC | 10% Owner | 08/07/2015 | 856,917,075,520 |
Aguiar Michael W | President & CEO | 06/02/2015 | 411,963 |
Tyree James L | Director | 06/02/2015 | 41,080 |
WALTRIP WILLIAM H | Director | 05/27/2015 | 219,410 |
WALTRIP WILLIAM H | Director | 05/27/2015 | 266,228 |
Aguiar Michael W | President & CEO | 05/20/2015 | 52,877 |
Aguiar Michael W | President & CEO | 02/20/2015 | 123,696 |
GLAXOSMITHKLINE PLC | 10% Owner | 05/11/2015 | 117,179,901,540 |
GLAXOSMITHKLINE PLC | 10% Owner | 03/02/2015 | 155,107,547,060 |
Aguiar Michael W | President & CEO | 02/20/2015 | 123,696 |
GLAXOSMITHKLINE PLC | 10% Owner | 11/04/2014 | 10,644,198,644,000 |
LEE JUNNING | Sr. VP, Technical Operations | 08/20/2014 | 74,220 |
Mammen Mathai | SVP, Research & Early Clin Dev | 08/20/2014 | 74,220 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/20/2014 | 74,220 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 08/20/2014 | 74,220 |
LEE JUNNING | Sr. VP, Technical Operations | 08/13/2014 | 926,264 |
LEE JUNNING | Sr. VP, Technical Operations | 08/13/2014 | 1,202,040 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/11/2014 | 489,182 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/12/2014 | 23,370 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/11/2014 | 599,629 |
GLAXOSMITHKLINE PLC | 10% Owner | 08/11/2014 | 675,457,327,770 |
GLAXOSMITHKLINE PLC | 10% Owner | 05/09/2014 | 2,715,293,806,800 |
Winningham Rick E | Chief Executive Officer | 05/09/2014 | 1,349,044 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 05/09/2014 | 613,294 |
Mammen Mathai | SVP, Research & Early Clin Dev | 05/09/2014 | 613,294 |
LEE JUNNING | Sr. VP, Technical Operations | 05/09/2014 | 393,499 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 05/09/2014 | 506,284 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 05/09/2014 | 574,938 |
Gunderson Robert V JR | Director | 04/17/2014 | 249,996 |
YOUNG WILLIAM D | Director | 04/07/2014 | 249,996 |
WALTRIP WILLIAM H | Director | 03/31/2014 | 249,996 |
LEVINE ARNOLD J | Director | 03/21/2014 | 249,996 |
Mammen Mathai | SVP, Research & Early Clin Dev | 03/06/2014 | 627,997 |
WHITESIDES GEORGE M | Director | 03/06/2014 | 249,996 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 03/03/2014 | 937,488 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 03/03/2014 | 2,417,314 |
Winningham Rick E | Chief Executive Officer | 02/20/2014 | 371,694 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2014 | 172,314 |
Mammen Mathai | SVP, Research & Early Clin Dev | 02/20/2014 | 172,194 |
LEE JUNNING | Sr. VP, Technical Operations | 02/20/2014 | 154,083 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 02/20/2014 | 172,354 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 02/20/2014 | 171,994 |
Mammen Mathai | SVP, Research & Early Clin Dev | 02/14/2014 | 1,377,688 |
GLAXOSMITHKLINE PLC | 10% Owner | 02/11/2014 | 4,397,882,210,300 |
Winningham Rick E | Chief Executive Officer | 11/20/2013 | 365,674 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/20/2013 | 166,312 |
Mammen Mathai | SVP, Research & Early Clin Dev | 11/20/2013 | 166,312 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 11/20/2013 | 166,312 |
GLAXOSMITHKLINE PLC | 10% Owner | 10/29/2013 | 641,093,437,530 |
Winningham Rick E | Chief Executive Officer | 09/12/2013 | 894,791 |
Winningham Rick E | Chief Executive Officer | 08/20/2013 | 360,551 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/20/2013 | 135,413 |
Mammen Mathai | SVP, Research & Early Clin Dev | 08/20/2013 | 136,849 |
Mammen Mathai | SVP, Research & Early Clin Dev | 08/21/2013 | 300,000 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/20/2013 | 164,017 |
Mammen Mathai | SVP, Research & Early Clin Dev | 07/30/2013 | 255,570 |
GLAXOSMITHKLINE PLC | 10% Owner | 07/30/2013 | 342,756,987,357,000 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 06/07/2013 | 1,087,572 |
Mammen Mathai | SVP, Research & Early Clin Dev | 05/29/2013 | 94,159 |
Brinkley David L | Head of Business Dev. | 05/29/2013 | 133,318 |
Winningham Rick E | Chief Executive Officer | 05/20/2013 | 371,802 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 05/20/2013 | 121,837 |
Mammen Mathai | SVP, Research & Early Clin Dev | 05/20/2013 | 121,837 |
Brinkley David L | Head of Business Dev. | 05/20/2013 | 90,415 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 05/20/2013 | 121,837 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 05/20/2013 | 169,136 |
Brinkley David L | Head of Business Dev. | 05/13/2013 | 548,386 |
Brinkley David L | Head of Business Dev. | 05/13/2013 | 650,483 |
Brinkley David L | Head of Business Dev. | 05/03/2013 | 478,225 |
Brinkley David L | Head of Business Dev. | 05/03/2013 | 560,805 |
Mammen Mathai | SVP, Research & Early Clin Dev | 04/30/2013 | 236,164 |
Brinkley David L | Head of Business Dev. | 04/30/2013 | 51,248 |
Brinkley David L | Head of Business Dev. | 04/30/2013 | 577,490 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 04/30/2013 | 3,060,443 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 04/30/2013 | 5,776,341 |
Winningham Rick E | Chief Executive Officer | 04/30/2013 | 3,731,247 |
Winningham Rick E | Chief Executive Officer | 04/30/2013 | 8,597,169 |
GLAXOSMITHKLINE PLC | 10% Owner | 04/30/2013 | 1,296,721,120,860 |
Winningham Rick E | Chief Executive Officer | 02/20/2013 | 235,476 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2013 | 110,588 |
Mammen Mathai | SVP, Research & Early Clin Dev | 02/20/2013 | 110,544 |
Mammen Mathai | SVP, Research & Early Clin Dev | 02/20/2013 | 154,980 |
Brinkley David L | Head of Business Dev. | 02/20/2013 | 75,494 |
GLAXOSMITHKLINE PLC | 10% Owner | 02/15/2013 | 299,135,296,430 |
Mammen Mathai | SVP, Research & Early Clin Dev | 01/11/2013 | 44,981 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/20/2012 | 102,744 |
Mammen Mathai | SVP, Research & Early Clin Dev | 11/20/2012 | 102,744 |
Brinkley David L | Head of Business Dev. | 11/20/2012 | 64,378 |
Mammen Mathai | SVP, Research & Early Clin Dev | 11/14/2012 | 15,999 |
Mammen Mathai | SVP, Research & Early Clin Dev | 11/02/2012 | 150,162 |
GLAXOSMITHKLINE PLC | 10% Owner | 11/02/2012 | 1,756,598,891,440 |
Brinkley David L | Head of Business Dev. | 08/24/2012 | 95,783 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/24/2012 | 73,807 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/27/2012 | 561,855 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/24/2012 | 115,429 |
Winningham Rick E | Chief Executive Officer | 08/20/2012 | 288,494 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/20/2012 | 124,138 |
Mammen Mathai | SVP, Research & Early Clin Dev | 08/20/2012 | 125,434 |
Brinkley David L | Head of Business Dev. | 08/20/2012 | 82,570 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/20/2012 | 131,728 |
Mammen Mathai | SVP, Research & Early Clin Dev | 08/13/2012 | 643,461 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/07/2012 | 975,000 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/07/2012 | 1,622,400 |
Brinkley David L | Head of Business Dev. | 08/03/2012 | 840,955 |
Brinkley David L | Head of Business Dev. | 08/03/2012 | 3,459,763 |
Winningham Rick E | Chief Executive Officer | 08/03/2012 | 449,999 |
Winningham Rick E | Chief Executive Officer | 08/03/2012 | 2,117,306 |
GLAXOSMITHKLINE PLC | 10% Owner | 08/03/2012 | 8,923,782 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 07/30/2012 | 224,041 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 05/29/2012 | 445,800 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 05/20/2012 | 77,905 |
Mammen Mathai | SVP, Research & Early Clin Dev | 05/20/2012 | 77,905 |
Brinkley David L | Head of Business Dev. | 05/20/2012 | 48,833 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 05/20/2012 | 77,905 |
Winningham Rick E | Chief Executive Officer | 05/20/2012 | 217,145 |
GLAXOSMITHKLINE PLC | 10% Owner | 05/16/2012 | 212,887,001 |
Winningham Rick E | Chief Executive Officer | 05/04/2012 | 400,070 |
DRAZAN JEFFREY M | Director | 05/01/2012 | 186,402 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2012 | 178,373 |
Mammen Mathai | SVP, Research & Early Clin Dev | 02/20/2012 | 180,709 |
Brinkley David L | Head of Business Dev. | 02/20/2012 | 98,596 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 02/20/2012 | 185,734 |
Winningham Rick E | Chief Executive Officer | 02/20/2012 | 396,496 |
GLAXOSMITHKLINE PLC | 10% Owner | 02/14/2012 | 1,603,040 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 12/09/2011 | 218,600 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/28/2011 | 257,649 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/28/2011 | 420,000 |
DRAZAN JEFFREY M | Director | 11/28/2011 | 90,153 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/20/2011 | 47,383 |
Mammen Mathai | SVP, Research & Early Clin Dev | 11/20/2011 | 50,265 |
Brinkley David L | Head of Business Dev. | 11/20/2011 | 42,156 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 11/20/2011 | 56,565 |
Winningham Rick E | Chief Executive Officer | 11/20/2011 | 138,910 |
GLAXOSMITHKLINE PLC | 10% Owner | 11/01/2011 | 1,298,477 |
Mammen Mathai | SVP, Research & Early Clin Dev | 09/01/2011 | 27,493 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/20/2011 | 37,100 |
Mammen Mathai | SVP, Research & Early Clin Dev | 08/20/2011 | 39,340 |
Brinkley David L | Head of Business Dev. | 08/20/2011 | 33,058 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/20/2011 | 44,310 |
GLAXOSMITHKLINE PLC | 10% Owner | 08/02/2011 | 2,019,605 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 06/14/2011 | 326,322 |
DRAZAN JEFFREY M | Director | 06/06/2011 | 861,900 |
DRAZAN JEFFREY M | Director | 06/07/2011 | 743,114 |
Brinkley David L | Head of Business Dev. | 05/31/2011 | 449,342 |
Brinkley David L | Head of Business Dev. | 05/27/2011 | 524,342 |
Brinkley David L | Head of Business Dev. | 05/31/2011 | 1,320,975 |
Brinkley David L | Head of Business Dev. | 05/27/2011 | 1,463,222 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 05/20/2011 | 53,916 |
Mammen Mathai | SVP, Research & Early Clin Dev | 05/20/2011 | 57,203 |
Brinkley David L | Head of Business Dev. | 05/20/2011 | 47,979 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 05/20/2011 | 64,388 |
Winningham Rick E | Chief Executive Officer | 05/11/2011 | 1,921,068 |
Winningham Rick E | Chief Executive Officer | 05/10/2011 | 1,443,201 |
GLAXOSMITHKLINE PLC | 10% Owner | 05/03/2011 | 6,689,254 |
Brinkley David L | Head of Business Dev. | 03/16/2011 | 6,510 |
Brinkley David L | Head of Business Dev. | 03/15/2011 | 348,837 |
Brinkley David L | Head of Business Dev. | 03/15/2011 | 1,004,463 |
Brinkley David L | Head of Business Dev. | 03/16/2011 | 46,242 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 03/11/2011 | 146,760 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 03/11/2011 | 460,617 |
YOUNG WILLIAM D | Director | 03/07/2011 | 91,661 |
YOUNG WILLIAM D | Director | 03/07/2011 | 119,939 |
Winningham Rick E | Chief Executive Officer | 03/01/2011 | 1,439,059 |
Winningham Rick E | Chief Executive Officer | 02/24/2011 | 1,158,974 |
Winningham Rick E | Chief Executive Officer | 02/28/2011 | 867,436 |
Winningham Rick E | Chief Executive Officer | 02/25/2011 | 1,158,121 |
Winningham Rick E | Chief Executive Officer | 02/28/2011 | 1,544,030 |
Winningham Rick E | Chief Executive Officer | 02/25/2011 | 2,070,524 |
Winningham Rick E | Chief Executive Officer | 02/24/2011 | 1,996,995 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2011 | 69,998 |
Mammen Mathai | SVP, Research & Early Clin Dev | 02/20/2011 | 72,900 |
Mammen Mathai | SVP, Research & Early Clin Dev | 02/18/2011 | 85,567 |
Brinkley David L | Head of Business Dev. | 02/20/2011 | 55,800 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 02/20/2011 | 78,998 |
Winningham Rick E | Chief Executive Officer | 02/20/2011 | 152,775 |
Winningham Rick E | Chief Executive Officer | 02/23/2011 | 1,214,812 |
Winningham Rick E | Chief Executive Officer | 02/22/2011 | 2,200,643 |
Winningham Rick E | Chief Executive Officer | 02/23/2011 | 2,063,264 |
Winningham Rick E | Chief Executive Officer | 02/22/2011 | 3,624,800 |
YOUNG WILLIAM D | Director | 02/18/2011 | 91,661 |
YOUNG WILLIAM D | Director | 02/18/2011 | 124,831 |
GLAXOSMITHKLINE PLC | 10% Owner | 02/18/2011 | 3,608,989 |
Mammen Mathai | SVP, Research & Early Clin Dev | 01/28/2011 | 83,869 |
YOUNG WILLIAM D | Director | 12/10/2010 | 91,678 |
YOUNG WILLIAM D | Director | 12/10/2010 | 143,243 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 12/03/2010 | 265,100 |
Brinkley David L | Head of Business Dev. | 12/01/2010 | 47,352 |
Brinkley David L | Head of Business Dev. | 12/01/2010 | 501,400 |
GLAXOSMITHKLINE PLC | 10% Owner | 11/29/2010 | 129,375,000 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/20/2010 | 54,116 |
Mammen Mathai | SVP, Research & Early Clin Dev | 11/20/2010 | 57,021 |
Brinkley David L | Head of Business Dev. | 11/20/2010 | 39,793 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 11/20/2010 | 63,371 |
Winningham Rick E | Chief Executive Officer | 11/20/2010 | 125,099 |
Brinkley David L | Head of Business Dev. | 09/14/2010 | 29,938 |
Mammen Mathai | SVP, Research & Early Clin Dev | 09/07/2010 | 54,995 |
Mammen Mathai | SVP, Research & Early Clin Dev | 09/01/2010 | 56,701 |
Winningham Rick E | Chief Executive Officer | 08/20/2010 | 50,736 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/20/2010 | 21,602 |
Mammen Mathai | SVP, Research & Early Clin Dev | 08/20/2010 | 23,394 |
Brinkley David L | Head of Business Dev. | 08/20/2010 | 12,698 |
Aguiar Michael W | Sr VP, Chief Financial Officer | 08/20/2010 | 27,370 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 10,352,073 | 0.00423% | 9.62% | Other |
RENAISSANCE TECHNOLOGIES LLC | 4,144,447 | 0.1% | 3.63% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,311,272 | 0.0022% | 3.01% | Other |
D. E. SHAW & CO., INC. | 771,018 | 0.01% | 8.5% | Other |
AQR CAPITAL MANAGEMENT LLC | 199,350 | 0.00602% | -35.53% | Other |
ROYCE & ASSOCIATES LP | 84,177 | 0.01% | -27.78% | Value |
BALYASNY ASSET MANAGEMENT L.P. | 78,785 | 0.00237% | 87.32% | Event Driven |
GOTHAM ASSET MANAGEMENT, LLC | 24,594 | 0.00732% | 35.12% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View